Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
Dr.Hugh M. Davis
Dr.Hugh M. Davis

COO of Biosion; President of Biosion USA


Biosion, Inc.

Dr. Davis is currently the Chief Operating Officer of Biosion, Inc. & President, Biosion, USA, Inc.  Dr. Davis brings to Biosion over 30 years of global Research & Development experience in the biotech and pharmaceutical industries. Dr. Davis joined Biosion from Frontage Laboratories, Inc., where he served as Chief Business Officer, leading the company to a very successful IPO in May of 2019. Prior to Frontage, Dr. Davis worked with Johnson & Johnson where he served as Vice President and Head of Biologics Development Sciences and China Biologics Leader in the Janssen Biotherapeutics division of Janssen R&D, LLC since 2001. During his tenure in J&J, Hugh and his team were instrumental in the development and approval of many biologic therapies including Remicade, Stelara, Simponi, Sylvant, Darzalex and Tremfya.  Prior to J&J, Hugh led the Pharmacodynamics & Exploratory Research Laboratory in the Clinical Pharmacology Unit at Glaxo SmithKline from 1996 to 2001.  Dr. Davis holds a Ph.D. degree in Biochemistry from Villanova University and completed his Post-Doctoral training at Centocor, Inc.